
News • In addition to AstraZeneca and Pfizer
Alternating vaccines trial expands to include Moderna and Novavax
Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, announce that the programme will be extended to include the Moderna and Novavax vaccines in a new study.